TY - JOUR
T1 - Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume
T2 - A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)
AU - Messroghli, Daniel R.
AU - Moon, James C.
AU - Ferreira, Vanessa M.
AU - Grosse-Wortmann, Lars
AU - He, Taigang
AU - Kellman, Peter
AU - Mascherbauer, Julia
AU - Nezafat, Reza
AU - Salerno, Michael
AU - Schelbert, Erik B.
AU - Taylor, Andrew J.
AU - Thompson, Richard
AU - Ugander, Martin
AU - Van Heeswijk, Ruud B.
AU - Friedrich, Matthias G.
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/10/9
Y1 - 2017/10/9
N2 - Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR). Parametric mapping with CMR now permits the routine spatial visualization and quantification of changes in myocardial composition based on changes in T1, T2, and T2 (star) relaxation times and extracellular volume (ECV). These changes include specific disease pathways related to mainly intracellular disturbances of the cardiomyocyte (e.g., iron overload, or glycosphingolipid accumulation in Anderson-Fabry disease); extracellular disturbances in the myocardial interstitium (e.g., myocardial fibrosis or cardiac amyloidosis from accumulation of collagen or amyloid proteins, respectively); or both (myocardial edema with increased intracellular and/or extracellular water). Parametric mapping promises improvements in patient care through advances in quantitative diagnostics, inter- and intra-patient comparability, and relatedly improvements in treatment. There is a multitude of technical approaches and potential applications. This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
AB - Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR). Parametric mapping with CMR now permits the routine spatial visualization and quantification of changes in myocardial composition based on changes in T1, T2, and T2 (star) relaxation times and extracellular volume (ECV). These changes include specific disease pathways related to mainly intracellular disturbances of the cardiomyocyte (e.g., iron overload, or glycosphingolipid accumulation in Anderson-Fabry disease); extracellular disturbances in the myocardial interstitium (e.g., myocardial fibrosis or cardiac amyloidosis from accumulation of collagen or amyloid proteins, respectively); or both (myocardial edema with increased intracellular and/or extracellular water). Parametric mapping promises improvements in patient care through advances in quantitative diagnostics, inter- and intra-patient comparability, and relatedly improvements in treatment. There is a multitude of technical approaches and potential applications. This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
UR - http://www.scopus.com/inward/record.url?scp=85031043505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031043505&partnerID=8YFLogxK
U2 - 10.1186/s12968-017-0389-8
DO - 10.1186/s12968-017-0389-8
M3 - Review article
C2 - 28992817
AN - SCOPUS:85031043505
SN - 1097-6647
VL - 19
JO - Journal of Cardiovascular Magnetic Resonance
JF - Journal of Cardiovascular Magnetic Resonance
IS - 1
M1 - 75
ER -